Q3151360 (Q3151360): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: Edited by the materialized bot - inferring region from the coordinates) |
(Created claim: summary (P836): Objective: Evaluate the effectiveness and cost-effectiveness of the complex MultiPAP Plus intervention to improve prescription in the young elderly population (65 to 74 years) with multimorbidity and polymedication in PA follow-up compared to the usual practice. Design: A pragmatic trial randomised by clusters with a follow-up of 18 months. Randomisation unit: professional, Analysis Unit: I'm patient. Scope: Health centres in three autonomous co...) |
||||||||||||||
| Property / summary | |||||||||||||||
Objective: Evaluate the effectiveness and cost-effectiveness of the complex MultiPAP Plus intervention to improve prescription in the young elderly population (65 to 74 years) with multimorbidity and polymedication in PA follow-up compared to the usual practice. Design: A pragmatic trial randomised by clusters with a follow-up of 18 months. Randomisation unit: professional, Analysis Unit: I'm patient. Scope: Health centres in three autonomous communities (Aragón, Madrid and Andalusia). Population: Patients aged 65-74 years with multimorbidity (=3 chronic diseases) and polymedication (=5 drugs) consumed for 3 months. Sample size: N=1234 patients (617 in each branch, 8 patients per physician) will be included by 155 family physicians before being randomised. Intervention: Complex intervention based on the ARIADNE principles with two components: 1) training, patient-centred and aimed at professionals; and 2) support system for decision-making in the care process. Result variables: principal: Hospitalisations or mortality; secondary schools: Use of services, quality of life (EuroQol 5D-5L), disability (WHODAS), fractures, pharmacotherapy and adherence to treatment (Morisky-Green), clinics and sociodemographics. Main result analysis: percentage difference in the final variable combined between 0 (T0) and 18 months (T3), with its corresponding 95 % CI. It will be adjusted for confusion and prognostic factors with a multilevel analysis. All analyses shall be carried out according to the principle of intent to deal. (English) | |||||||||||||||
| Property / summary: Objective: Evaluate the effectiveness and cost-effectiveness of the complex MultiPAP Plus intervention to improve prescription in the young elderly population (65 to 74 years) with multimorbidity and polymedication in PA follow-up compared to the usual practice. Design: A pragmatic trial randomised by clusters with a follow-up of 18 months. Randomisation unit: professional, Analysis Unit: I'm patient. Scope: Health centres in three autonomous communities (Aragón, Madrid and Andalusia). Population: Patients aged 65-74 years with multimorbidity (=3 chronic diseases) and polymedication (=5 drugs) consumed for 3 months. Sample size: N=1234 patients (617 in each branch, 8 patients per physician) will be included by 155 family physicians before being randomised. Intervention: Complex intervention based on the ARIADNE principles with two components: 1) training, patient-centred and aimed at professionals; and 2) support system for decision-making in the care process. Result variables: principal: Hospitalisations or mortality; secondary schools: Use of services, quality of life (EuroQol 5D-5L), disability (WHODAS), fractures, pharmacotherapy and adherence to treatment (Morisky-Green), clinics and sociodemographics. Main result analysis: percentage difference in the final variable combined between 0 (T0) and 18 months (T3), with its corresponding 95 % CI. It will be adjusted for confusion and prognostic factors with a multilevel analysis. All analyses shall be carried out according to the principle of intent to deal. (English) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / summary: Objective: Evaluate the effectiveness and cost-effectiveness of the complex MultiPAP Plus intervention to improve prescription in the young elderly population (65 to 74 years) with multimorbidity and polymedication in PA follow-up compared to the usual practice. Design: A pragmatic trial randomised by clusters with a follow-up of 18 months. Randomisation unit: professional, Analysis Unit: I'm patient. Scope: Health centres in three autonomous communities (Aragón, Madrid and Andalusia). Population: Patients aged 65-74 years with multimorbidity (=3 chronic diseases) and polymedication (=5 drugs) consumed for 3 months. Sample size: N=1234 patients (617 in each branch, 8 patients per physician) will be included by 155 family physicians before being randomised. Intervention: Complex intervention based on the ARIADNE principles with two components: 1) training, patient-centred and aimed at professionals; and 2) support system for decision-making in the care process. Result variables: principal: Hospitalisations or mortality; secondary schools: Use of services, quality of life (EuroQol 5D-5L), disability (WHODAS), fractures, pharmacotherapy and adherence to treatment (Morisky-Green), clinics and sociodemographics. Main result analysis: percentage difference in the final variable combined between 0 (T0) and 18 months (T3), with its corresponding 95 % CI. It will be adjusted for confusion and prognostic factors with a multilevel analysis. All analyses shall be carried out according to the principle of intent to deal. (English) / qualifier | |||||||||||||||
point in time: 12 October 2021
| |||||||||||||||
Revision as of 15:26, 12 October 2021
Project Q3151360 in Spain
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | No label defined |
Project Q3151360 in Spain |
Statements
18,650.0 Euro
0 references
37,300.0 Euro
0 references
50.0 percent
0 references
1 January 2019
0 references
31 March 2022
0 references
INSTITUTO ARAGONES DE CIENCIAS DE LA SALUD
0 references
41°39'7.67"N, 0°52'51.38"W
0 references
50297
0 references
Objetivo: Evaluar la efectividad y coste-efectividad de la intervención compleja MultiPAP Plus para mejorar la prescripción en población anciana joven (65 a 74 años) con multimorbilidad y polimedicación en seguimiento en AP comparada con la práctica habitual. Diseño: Ensayo clínico pragmático aleatorizado por conglomerados con un seguimiento de 18 meses. Unidad de aleatorización: profesional, Unidad de análisis: paciente. Ámbito: Centros de salud de tres comunidades autónomas (Aragón, Madrid y Andalucía). Población: Pacientes entre 65-74 años con multimorbilidad (=3 enfermedades crónicas) y polimedicación (=5 fármacos) consumidos durante 3 meses. Tamaño muestral: n=1234 pacientes (617 en cada rama, 8 pacientes por médico) serán incluidos por 155 médicos de familia antes de ser aleatorizados. Intervención: Intervención compleja basada en los principios ARIADNE con dos componentes: 1) formativo, centrado en el paciente y dirigido a profesionales; y 2) sistema de apoyo a la toma de decisiones en el proceso de atención. Variables resultado: a) Principal: Hospitalizaciones y/o mortalidad; b) Secundarias: Utilización de servicios, calidad de vida (Euroqol 5D-5L), discapacidad (WHODAS), fracturas, farmacoterapia y adherencia al tratamiento (Morisky-Green), clínicas y sociodemográficas. Análisis de resultado principal: diferencia de porcentajes en la variable final combinada entre 0 (T0) y 18 meses (T3), con su correspondiente IC95%. Se ajustará por factores de confusión y pronóstico con un análisis multinivel. Todos los análisis se efectuarán según el principio de intención de tratar. (Spanish)
0 references
Objective: Evaluate the effectiveness and cost-effectiveness of the complex MultiPAP Plus intervention to improve prescription in the young elderly population (65 to 74 years) with multimorbidity and polymedication in PA follow-up compared to the usual practice. Design: A pragmatic trial randomised by clusters with a follow-up of 18 months. Randomisation unit: professional, Analysis Unit: I'm patient. Scope: Health centres in three autonomous communities (Aragón, Madrid and Andalusia). Population: Patients aged 65-74 years with multimorbidity (=3 chronic diseases) and polymedication (=5 drugs) consumed for 3 months. Sample size: N=1234 patients (617 in each branch, 8 patients per physician) will be included by 155 family physicians before being randomised. Intervention: Complex intervention based on the ARIADNE principles with two components: 1) training, patient-centred and aimed at professionals; and 2) support system for decision-making in the care process. Result variables: principal: Hospitalisations or mortality; secondary schools: Use of services, quality of life (EuroQol 5D-5L), disability (WHODAS), fractures, pharmacotherapy and adherence to treatment (Morisky-Green), clinics and sociodemographics. Main result analysis: percentage difference in the final variable combined between 0 (T0) and 18 months (T3), with its corresponding 95 % CI. It will be adjusted for confusion and prognostic factors with a multilevel analysis. All analyses shall be carried out according to the principle of intent to deal. (English)
12 October 2021
0 references
Zaragoza
0 references
Identifiers
PI18_01303
0 references